Losartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ by Hetero Labs, Limited, Mahabubragar, India
Published September 2, 2020 · Recall initiated: August 6, 2020
Summary
FDA records drug Class II recall D-1545-2020, published September 2, 2020 and initiated August 6, 2020. Recalling firm: Hetero Labs Limited (Unit V); Status: Terminated; Reported quantity: 43,512 bottles; Lot: Batch # LOA19357A, exp. date 09/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specification; complaint of bulging tablet
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Hetero Labs Limited (Unit V)
- Distributor
- Product was distributed to major wholesalers/distributors throughout the United States.
- Lot
- Batch # LOA19357A, exp. date 09/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAPantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: CamberApril 29, 2026
- FDAMetformin Hydrochloride Extended-Release Tablets USP, 750 mg 100 Tablets Rx Only Manufactured by: BeximcoSeptember 2, 2020
- FDAHand Sanitizer Disinfectant Gel 70% Ethyl Alcohol, packaged in 6.7 FL Oz. (200 mL) bottles, Distributed by:September 2, 2020
- FDAMetformin Hydrochloride Extended-Release Tablets USP, 500 mg 1000 Tablets Rx Only Manufactured by: BeximcoSeptember 2, 2020
- FDAHAND SANITIZER Non-sterile Solution 70% Topical Solution, packaged in 20L (5.28 Gal) plastic containers,September 2, 2020
- FDABusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01September 2, 2020
Questions about this recall
Was Losartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ by Hetero Labs, Limited, Mahabubragar, India recalled?
Yes. FDA published recall D-1545-2020 on September 2, 2020. Reported hazard: Failed Tablet/Capsule Specification; complaint of bulging tablet
What should I do if I have this product?
Voluntary: Firm initiated · Letter